Charcot-Marie-Tooth Disease, Type IA
9 clinical trials · Condition
◉ Watch Charcot-Marie-Tooth Disease, Type IA
| Record | Firm | Date |
|---|---|---|
| Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A (NCT05333406) | ENCell | 2022-02-22 |
| Muscle MRI in Charcot Mary Tooth Disease: a Prospective Cohort Study (NCT03550300) | University College, London | 2018-09-11 |
| Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker) (NCT03386266) | University Medical Center Goettingen | 2017-08-11 |
| Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A (NCT03023540) | Pharnext S.C.A. | 2017-03-07 |
| BALTiC Study: A Feasibility Analysis of Home Based BALance Training in People With Charcot-Marie-Tooth Disease (NCT02982343) | University College London Hospitals | 2016-12-01 |
| Natural History Study for Charcot Marie Tooth Disease (NCT05902351) | Hereditary Neuropathy Foundation | 2013-11-01 |
| High Dose Ascorbic Acid Treatment of CMT1A (NCT00484510) | Wayne State University | 2007-04-01 |
Track Charcot-Marie-Tooth Disease, Type IA automatically
Every clearance here is in the API, with alerts when new ones post.